Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 15 | $18,250,796 |
| Sells | 28 | $15,900,286 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 13 Mar 2025 20:00 | SRPT | Sarepta Therapeutics Inc | NICAISE CLAUDE | Director | 12 Mar 2025 | Sale | 2,491 | 99.64 | 248,203 | D |
| 16 Dec 2024 20:00 | SRPT | Sarepta Therapeutics Inc | WIGZELL HANS LENNART RUDOLF | Director | 12 Dec 2024 | Sale | 10,500 | 124.84 | 1,310,820 | D |
| 06 Dec 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BOOR KATHRYN JEAN | Director | 05 Dec 2024 | Sale | 1,636 | 125.55 | 205,400 | D |
| 03 Sep 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ESTEPAN IAN MICHAEL | Chief Financial Officer | 30 Aug 2024 | Sale | 5,985 | 137.36 | 822,100 | D |
| 20 Aug 2024 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 16 Aug 2024 | Purchase | 5,648 | 134.66 | 760,560 | I |
| 20 Aug 2024 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 16 Aug 2024 | Purchase | 18,284 | 134.06 | 2,451,153 | I |
| 20 Aug 2024 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 16 Aug 2024 | Purchase | 13,106 | 133.07 | 1,744,015 | I |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BROWN RYAN EDWARD | EVP, General Counsel | 25 Jun 2024 | Sale | 2,549 | 164.52 | 419,361 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BROWN RYAN EDWARD | EVP, General Counsel | 25 Jun 2024 | Sale | 3,840 | 163.53 | 627,955 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BROWN RYAN EDWARD | EVP, General Counsel | 25 Jun 2024 | Sale | 17,581 | 162.65 | 2,859,550 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BROWN RYAN EDWARD | EVP, General Counsel | 25 Jun 2024 | Sale | 4,168 | 161.82 | 674,466 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BROWN RYAN EDWARD | EVP, General Counsel | 25 Jun 2024 | Sale | 975 | 160.31 | 156,302 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BROWN RYAN EDWARD | EVP, General Counsel | 25 Jun 2024 | Sale | 2,200 | 159.14 | 350,108 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BROWN RYAN EDWARD | EVP, General Counsel | 25 Jun 2024 | Sale | 7,644 | 158.07 | 1,208,287 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ARIF BILAL | Chief Tech Ops Officer | 25 Jun 2024 | Sale | 3,898 | 163.23 | 636,271 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ARIF BILAL | Chief Tech Ops Officer | 24 Jun 2024 | Sale | 224 | 167.13 | 37,437 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ARIF BILAL | Chief Tech Ops Officer | 24 Jun 2024 | Sale | 300 | 164.61 | 49,383 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ARIF BILAL | Chief Tech Ops Officer | 24 Jun 2024 | Sale | 700 | 166.1 | 116,270 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ARIF BILAL | Chief Tech Ops Officer | 24 Jun 2024 | Sale | 1,055 | 163.83 | 172,841 | D |
| 25 Jun 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ARIF BILAL | Chief Tech Ops Officer | 24 Jun 2024 | Sale | 5,580 | 162.31 | 905,690 | D |
| 06 May 2024 20:09 | SRPT | Sarepta Therapeutics Inc | MURRAY DALLAN | Chief Customer Officer | 02 May 2024 | Sale | 3,635 | 140 | 508,900 | D |
| 11 Mar 2024 20:02 | SRPT | Sarepta Therapeutics Inc | WIGZELL HANS LENNART RUDOLF | Director | 08 Mar 2024 | Sale | 100 | 122.39 | 12,239 | D |
| 11 Mar 2024 20:02 | SRPT | Sarepta Therapeutics Inc | WIGZELL HANS LENNART RUDOLF | Director | 08 Mar 2024 | Sale | 3,155 | 123.85 | 390,747 | D |
| 11 Mar 2024 20:02 | SRPT | Sarepta Therapeutics Inc | WIGZELL HANS LENNART RUDOLF | Director | 08 Mar 2024 | Sale | 11,745 | 123.1 | 1,445,810 | D |
| 11 Mar 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BOOR KATHRYN JEAN | Director | 11 Mar 2024 | Sale | 761 | 122.93 | 93,550 | D |
| 06 Mar 2024 20:00 | SRPT | Sarepta Therapeutics Inc | MAYO STEPHEN | Director | 05 Mar 2024 | Sale | 3,135 | 122.96 | 385,480 | D |
| 05 Mar 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ARIF BILAL | Chief Tech Ops Officer | 01 Mar 2024 | Sale | 457 | 129.71 | 59,277 | D |
| 05 Mar 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ARIF BILAL | Chief Tech Ops Officer | 01 Mar 2024 | Sale | 1,543 | 128.58 | 198,399 | D |
| 05 Mar 2024 20:00 | SRPT | Sarepta Therapeutics Inc | ESTEPAN IAN MICHAEL | Chief Financial Officer | 01 Mar 2024 | Sale | 1,200 | 128.3 | 153,960 | D |
| 05 Mar 2024 20:00 | SRPT | Sarepta Therapeutics Inc | BROWN RYAN EDWARD | EVP, General Counsel | 01 Mar 2024 | Sale | 2,000 | 125.34 | 250,680 | D |
| 06 Nov 2023 08:00 | SRPT | Sarepta Therapeutics Inc | BARRY RICHARD | Director | 03 Nov 2023 | Purchase | 10,000 | 78.81 | 788,100 | I |
| 06 Nov 2023 08:00 | SRPT | Sarepta Therapeutics Inc | BARRY RICHARD | Director | 03 Nov 2023 | Purchase | 40,000 | 78.81 | 3,152,400 | I |
| 06 Nov 2023 08:00 | SRPT | Sarepta Therapeutics Inc | INGRAM DOUGLAS S | President & CEO | 03 Nov 2023 | Purchase | 200 | 81.26 | 16,252 | D |
| 06 Nov 2023 08:00 | SRPT | Sarepta Therapeutics Inc | INGRAM DOUGLAS S | President & CEO | 03 Nov 2023 | Purchase | 3,884 | 80.33 | 312,002 | D |
| 06 Nov 2023 08:00 | SRPT | Sarepta Therapeutics Inc | INGRAM DOUGLAS S | President & CEO | 03 Nov 2023 | Purchase | 11,060 | 79.7 | 881,482 | D |
| 06 Nov 2023 08:00 | SRPT | Sarepta Therapeutics Inc | INGRAM DOUGLAS S | President & CEO | 03 Nov 2023 | Purchase | 10,081 | 78.57 | 792,064 | D |
| 15 Aug 2023 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 14 Aug 2023 | Purchase | 4,032 | 109.89 | 443,076 | I |
| 15 Aug 2023 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 14 Aug 2023 | Purchase | 5,947 | 109.19 | 649,353 | I |
| 14 Aug 2023 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 11 Aug 2023 | Purchase | 23,686 | 108.05 | 2,559,272 | I |
| 11 Aug 2023 07:40 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 10 Aug 2023 | Purchase | 1,091 | 105.9 | 115,537 | I |
| 11 Aug 2023 07:40 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 10 Aug 2023 | Purchase | 31,570 | 106.26 | 3,354,628 | I |
| 11 Aug 2023 07:40 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 10 Aug 2023 | Purchase | 2,206 | 104.67 | 230,902 | I |
| 08 Aug 2023 20:00 | SRPT | Sarepta Therapeutics Inc | WIGZELL HANS LENNART RUDOLF | Director | 04 Aug 2023 | Sale | 15,000 | 106.72 | 1,600,800 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)